• Aoki, S. T., Settembre, E. C., Trask, S. D., Greenberg, H. B., Harrison, S. C., Dormitzer, P. R. 2009. Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 324:1444-7.

  • Bergman, H., Henschke, N., Hungerford, D., Pitan, F., Ndwandwe, D., Cunliffe, N., Soares-Weiser, K. 2021. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 11:CD008521.

  • CHen, H., Li, Q., Duan, K., Shi, C., Zhang, D., Dong, B., Bai, X., Qiao, J., Xu, G., Yang, X., Gao, Z., Li, F., Lv, H., Zhou, H., Yan, T., Shi, H. 2021. Molecular epidemiological characteristics of rotavirus VP7 gene in Zhengding County of Hebei Province, Xiangtan County of Hunan Province and Yuhuan City of Zhejiang Province, China from 2016 to 2017. Chinese Journal of Biologicals. 34: 415-427, 431.

  • Chen, S., Zhou, Y., Chen, Y., Gu, J. 2018. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 34: i884-i890

  • Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., Mccarthy, S. A., Davies, R. M., Li, H. 2021. Twelve years of SAMtools and BCFtools. Gigascience 10:giab008.

  • Desselberger, U. 2017. Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors. Pathogens. 6:65.

  • Doan, Y. H., Nakagomi, T., Cunliffe, N. A., Pandey, B. D., Sherchand, J. B., Nakagomi, O. 2011. The occurrence of amino acid substitutions D96N and S242N in VP7 of emergent G2P[4] rotaviruses in Nepal in 2004-2005: a global and evolutionary perspective. Arch Virol. 156:1969-78

  • Folorunso, O. S., Sebolai, O. M. 2020. Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines (Basel). 8:341

  • Geng, Q., Lai, S., Yu, J., Zhang, Z., Yang, W., Li, Z., Wu, J., Yang, W. 2016. Epidemiological characteristics of rotavirus caused diarrhea in children aged〈5 years in 26 provinces in China, 2011-2014. Disease Surveillance 31: 463-470

  • Gouvea, V., Brantly, M. 1995. Is Rotavirus a population of reassortants? Trends Microbiol. 3:159-62

  • Grant, L., Esona, M., Gentsch, J., Watt, J., Reid, R., Weatherholtz, R., Santosham, M., Parashar, U., O'brien, K. 2011. Detection of G3P[3] and G3P[9] rotavirus strains in American Indian children with evidence of gene reassortment between human and animal rotaviruses. J Med Virol 83:1288-99.

  • Hoshino, Y., Jones, R. W., Ross, J., Honma, S., Santos, N., Gentsch, J. R., Kapikian, A. Z. 2004. Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol. 78:7795-802

  • Jiao, Y., Han, T., Qi, X., Gao, Y., Zhao, J., Zhang, Y., Li, B., Zhang, Z., Du, J., Sun, L. 2023. Human rotavirus strains circulating among children in the capital of China (2018-2022)_ predominance of G9P[8] and emergence ofG8P[8]. Heliyon. 9:e18236

  • Kopylova, E., Noé, L., Touzet, H. 2012. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics. 28:3211-7

  • Li, R. C., Huang, T., Li, Y., Luo, D., Tao, J., Fu, B., Si, G., Nong, Y., Mo, Z., Liao, X., Luan, I., Tang, H., Rathi, N., Karkada, N., Han, H. H. 2014. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China. Hum Vaccin Immunother. 10:11-8

  • Lu, Y., Xie, H., Wang, D., Lu, J. 2021. Nosocomial infection caused by a rare G8P[8] rotavirus subtype in a pediatric unit in Guangzhou, Southern China. Hum Vaccin Immunother. 17:3619-3622

  • Maes, P., Matthijnssens, J., Rahman, M., Van Ranst, M. 2009. RotaC: a web-based tool for the complete genome classification of group A rotaviruses. BMC Microbiol. 9:238

  • Mao, T., Wang, M., Wang, J., Ma, Y., Liu, X., Wang, M., Sun, X., Li, L., Li, H., Zhang, Q., Li, D., Duan, Z. 2022. Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains. Front Cell Infect Microbio 12: 927490.

  • MIshra, N., Reslan, L., El-Husseini, M., Raoof, H., Finianos, M., Guo, C., Thakkar, R., Inati, A., Dbaibo, G., Lipkin, W. I., Zaraket, H. 2020. Full genome characterization of human G3P[6] and G3P[9] rotavirus strains in Lebanon. Infect Genet Evol. 78:104133

  • Mo, Z., Mo, Y., Li, M., Tao, J., Yang, X., Kong, J., Wei, D., Fu, B., Liao, X., Chu, J., Qiu, Y., Hille, D. A., Nelson, M., Kaplan, S. S. 2017. Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial. Vaccine. 5:5897-5904

  • Mwangi, P. N., Potgieter, R. L., Simwaka, J., Mpabalwani, E. M., Mwenda, J. M., Mogotsi, M. T., Magagula, N., Esona, M. D., Steele, A. D., Seheri, M. L., Nyaga, M. M. 2023. Genomic Analysis of G2P[4] Group A Rotaviruses in Zambia Reveals Positive Selection in Amino Acid Site 7 of Viral Protein 3. Viruses 15: 501

  • PArker, E. P., Ramani, S., Lopman, B. A., Church, J. A., Iturriza-Gómara, M., Prendergast, A. J., Grassly, N. C. 2018. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 3: 97-118

  • Prjibelski, A., Antipov, D., Meleshko, D., Lapidus, A., Korobeynikov, A. 2020. Using SPAdes De Novo Assembler. Curr Protoc Bioinformatics. 70: e102

  • Rasebotsa, S., Uwimana, J., Mogotsi, M. T., Rakau, K., Magagula, N. B., Seheri, M. L., Mwenda, J. M., Mphahlele, M. J., Sabiu, S., Mihigo, R., Mutesa, L., Nyaga, M. M. 2021. Whole-Genome Analyses Identifies Multiple Reassortant Rotavirus Strains in Rwanda Post-Vaccine Introduction. Viruses 13: 95

  • Ruiz-Palacios, G. M., Pérez-Schael, I., Velázquez, F. R., Abate, H., Breuer, T., Clemens, S. C., Cheuvart, B., Espinoza, F., Gillard, P., Innis, B. L., Cervantes, Y., Linhares, A. C., López, P., Macías-Parra, M., Ortega-Barría, E., Richardson, V., Rivera-Medina, D. M., Rivera, L., Salinas, B., Pavía-Ruz, N., Salmerón, J., Rüttimann, R., Tinoco, J. C., Rubio, P., Nuñez, E., Guerrero, M. L., Yarzábal, J. P., Damaso, S., Tornieporth, N., Sáez-Llorens, X., Vergara, R. F., Vesikari, T., Bouckenooghe, A., Clemens, R., De Vos, B., O'ryan, M. 2006. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 354:11-22

  • Sanger, F., Nicklen, S., Coulson, A. R. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 74:5463-7

  • Soares-Weiser, K., Bergman, H., Henschke, N., Pitan, F., Cunliffe, N. 2019. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019: CD008521

  • Tacharoenmuang, R., Komoto, S., Guntapong, R., Ide, T., Sinchai, P., Upachai, S., Yoshikawa, T., Tharmaphornpilas, P., Sangkitporn, S., Taniguchi, K. 2016. Full Genome Characterization of Novel DS-1-Like G8P[8] Rotavirus Strains that Have Emerged in Thailand: Reassortment of Bovine and Human Rotavirus Gene Segments in Emerging DS-1-Like Intergenogroup Reassortant Strains. PLoS One 11: e0165826

  • Theamboonlers, A., Maiklang, O., Thongmee, T., Chieochansin, T., Vuthitanachot, V., Poovorawan, Y. 2013. Complete genome analysis of a rare human G3P[9] rotavirus posing as an AU-1 like strain. Springerplus 2: 569

  • Vesikari, T., Clark, H. F., Offit, P. A., Dallas, M. J., Distefano, D. J., Goveia, M. G., Ward, R. L., Schödel, F., Karvonen, A., Drummond, J. E., Dinubile, M. J., Heaton, P. M. 2006. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine 24: 4821-9

  • Wang, S. J., Chen, L. N., Wang, S. M., Zhou, H. L., Qiu, C., Jiang, B., Qiu, T. Y., Chen, S. L., Von Seidlein, L., Wang, X. Y. 2022. Genetic characterization of two G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21: evidence of genome reassortment. BMC Infect Dis. 22: 579

  • Wei, Y., Li, J., Peng, R., Wang, M., Sun, X., Zhang, Q., Wang, H., Fan, J., Li, D., Duan, Z. 2022. Epidemiological and clinical characteristics of hospitalized children with G9P[8] group A rotavirus diarrhea in China from 2011 to 2019. Disease Surveillance. 2022:1-7

  • WHO, 2013. Rotavirus vaccines WHO position paper: January 2013 - Recommendations. Vaccine. 31:6170-1

  • Wu, Z., Li, Q., Liu, Y., Lv, H., Mo, Z., Li, F., Yu, Q., Jin, F., Chen, W., Zhang, Y., Huang, T., Hu, X., Xia, W., Gao, J., Zhou, H., Bai, X., Liu, Y., Liang, Z., Jiang, Z., Chen, Y., Zhang, J., Du, J., Yang, B., Xing, B., Xing, Y., Dong, B., Yang, Q., Shi, C., Yan, T., Ruan, B., Shi, H., Fan, X., Feng, D., Lv, W., Zhang, D., Kong, X., Zhou, L., Que, D., Chen, H., Chen, Z., Guo, X., Zhou, W., Wu, C., Zhou, Q., Liu, Y., Qiao, J., Wang, Y., Li, X., Duan, K., Zhao, Y., Yang, X., Xu, G. 2022. Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants. Virol Sin. 37: 724-730

  • Wu, Z. W., Li, Q. L., Zhou, H. S., Duan, K., Gao, Z., Zhang, X. J., Jiang, Z. J., Hao, Z. Y., Jin, F., Bai, X., Li, Q., Xu, G. L., Zhao, Y. L., Yang, X. M. 2021. Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial. Hum Vaccin Immunother. 17: 2311-2318

  • Xia, S., Du, J., Su, J., Liu, Y., Huang, L., Yu, Q., Xie, Z., Gao, J., Xu, B., Gao, X., Guo, T., Liu, Y., Zhou, X., Yang, H. 2020. Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial. Vaccine 38: 7393-7400.

  • Zeller, M., Patton, J. T., Heylen, E., De Coster, S., Ciarlet, M., Van Ranst, M., Matthijnssens, J. 2012. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol. 50:966-976

  • Zhang, T., Li, J., Jiang, Y. Z., Xu, J. Q., Guan, X. H., Wang, L. Q., Chen, J., Liang, Y. 2022. Genotype distribution and evolutionary analysis of rotavirus associated with acute diarrhea outpatients in Hubei, China, 2013-2016. Virol Sin. 37: 503-512.

  • Zhao, L., Shi, X., Meng, D., Guo, J., Li, Y., Liang, L., Guo, X., Tao, R., Zhang, X., Gao, R., Gao, L., Wang, J. 2021. Prevalence and genotype distribution of group A rotavirus circulating in Shanxi Province, China during 2015-2019. BMC Infect Dis. 21: 94

  • Zhou, X., Wang, Y., Chen, N., Pang, B., Liu, M., Cai, K., Kobayashi, N. 2023. Surveillance of Human Rotaviruses in Wuhan, China (2019-2022): Whole-Genome Analysis of Emerging DS-1-like G8P[8] Rotavirus. Int J Mol Sci. 24: 12189